Navigation Links
Sea Snail Venom Paves Way for Potent New Painkiller

Washington, Boffins have used the magical properties of the deadly sea snail venom to create a drug that can kill pain in humans.

The snail uses venom to paralyze passing fish, but scientists found that chemicals in the poison could also obstruct pain signals in the human brain.

About 25 years ago, scientists at the University of Utah, in the US, were able to detach a molecule from the venom that also had painkilling properties in humans.

Now researchers have produced a synthetic version of the compound with parallel pain-killing effects, and it forms the foundation of the new drug, Prialt.

Prialt is designed to ease persistent pains in people who suffer from various types of cancer and other very serious diseases. It is a very powerful drug, as it was created to lessen chronic pains in individuals that no longer responded to morphine therapy.

The treatment is expected to block the calcium channels of the nerves that transmit pain signals in the body. It targets a particular subgroup known as N-type calcium channels , which play a role in some kinds of pain.

Prialt is 1,000 times more potent than morphine but, unlike that drug, is not addictive.

The treatment based on synthetic venom will not be administered orally, but directly into the fluid around the spinal cord through a little push. However, it may have side effects such as nausea, dizziness or blurred vision due to the fact that it is a very strong drug.

Prialt, or ziconotide, is the result of more than 20 years research by a scientist born in the Philippines, Baldomera Olivera, who is a professor at the University of Utah.


'"/>




Page: 1

Related medicine news :

1. Snail venom Found To Ease Pain In Cancer Victims
2. Painkiller Based on Sea Snail Venom Made Available in Britain
3. Venomous Cone Snails Relieve Chronic Back Pain
4. Health Benefits from the Ocean Snail
5. A New Target for Painkillers: Snail Toxins Show the Way
6. Sea Snails May Aid Chronic Pain Treatments – Says Researcher
7. Bee Venom Effective In Reducing Inflammation
8. More Lizards, Including Pets, Found Venomous
9. Australian Snake Venom Can Arrest Bleeding During Surgery And Trauma
10. Arthritis Pain Can Be Eased Using Snake Venom
11. Brain Cancer Could be Safely Treated with Radioactive Scorpion Venom
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has ... today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, every formula ... the highest standard. , These products are also: Gluten Free, Non-GMO, Vegan, ...
(Date:10/12/2017)... ... ... Asante, a nationally recognized health system in southern Oregon, ... health joint venture through an agreement, effective October 1, 2017, to create AccentCare ... company with Asante, delivering clinically integrated care, for the past eight years. This ...
(Date:10/12/2017)... ... ... HMP , a leader in healthcare events and education, today announced that ... for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie Awards ... recognizes editorial and design excellence across a range of sectors. This year’s program included ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned ... Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. OnSite Wellness ... on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at the Henry ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a ... today announced that its MyDario product is expected to appear on The ... when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz ... The ...
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/19/2017)... -- HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy ... team developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D ...
Breaking Medicine Technology: